A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
Clinical trial NCT07589686 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07589686
- Sponsor
- Hoffmann-La Roche
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2027-11-12
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.